Patient Dosing Begins for Phase 3 Study of Once-Nightly Sodium Oxybate in Idiopathic Hypersomnia

Known as REVITALYZ, the double-blind, placebo-controlled study will assess the effect of once-nightly sodium oxybate on the primary end point of change in Epworth Sleepiness Scale over a 14-week period.:

Source: Neurology Read More